Translating advances in molecular oncology into improved care for patients with haematological malignancies [ 2015 - ]

Research Grant

Researchers: Prof Andrew Roberts (Principal investigator)

Brief description The purpose of my research is to develop and integrate into routine practice better treatment paradigms for patients with blood cancers – leukaemias, lymphomas, myeloma. My research seeks to (i) bring a new class of anti-cancer targeted therapy, inhibitors of Bcl-2, into routine care; (ii) discover the genetic changes that explain why slow growing lymphoid cancers change into rapidly fatal lymphomas; and (iii) integrate new molecular tests into the management of patients with acute leukaemia.

Funding Amount $394,017.00

Funding Scheme Practitioner Fellowships

Notes Practitioner Fellowship